Moxinix-LP
(Moxifloxacin 0.5% &Loteprednol 0.5% + SOC 0.005% ( As Preservative))
Improved formulation with SOC preservative
Moxifloxacin
- Treats conjunctival infection caused by susceptible bacteria and prevents infection following bye eye surgeries
Loteprednol
- Reduces conjunctival itching & infection
- Relieves the entire inflammatory cascade
- Lower incidences of IOP elevation
- Safe for Long term use